William Fletcher brings his serialization and traceability knowledge to the healthcare solutions company.
Knipper Health, a healthcare solutions company serving the pharma, biotech, and medical device industries, has appointed William “Bill” Fletcher as its senior director, traceability and electronic client communications.
Fletcher is an experienced executive with a 41-plus year history in the life sciences industry, with leadership roles in pharma and biotech packaging and labeling, research and development, warehousing, distribution and medical devices. His previous roles have included CTO, director of development, product director and program director for software, hardware and online solutions in life sciences.
For 18 years before joining Knipper Health, Fletcher was managing director of Pharma Logic Solutions, LLC, a consulting company that specializes in compliance with global traceability and serialization regulations. He has assisted over 65 manufacturers, wholesalers and 3PL and distribution providers to implement serialization systems, packaging, labeling and related procedures, with both internal or contracted manufacturing, packaging and distribution.
For decades, Fletcher has spoken to audiences of hundreds during industry events around the world and across the United States. In 2013, he was asked to share his experience by speaking in the U.S. Capitol to congressional staff developing the Federal Drug Quality and Security Act (DQSA) of 2013, and more specifically, its Title II, the Drug Supply Chain Security Act (DSCSA).
“I am excited to be a contributor for Knipper Health and Knipper 3PL, and have already felt the great sense of community here with my colleagues,” comments Fletcher. “This is a great time to join the company as we aim to solve many of the industry’s challenges with serialization and DQSA/DSCSA compliance and expand our services around the secure exchange of needed medications.”
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.